Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula
- PMID: 17441769
- PMCID: PMC2745555
- DOI: 10.1021/np0700772
Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula
Abstract
As part of the Panama International Cooperative Biodiversity Groups (ICBG) project, two new (2, 4) and two known (1, 3) linear alkynoic lipopeptides have been isolated from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. Carmabin A (1), dragomabin (2), and dragonamide A (3) showed good antimalarial activity (IC50 4.3, 6.0, and 7.7 microM, respectively), whereas the nonaromatic analogue, dragonamide B (4), was inactive. The planar structures of all four compounds were determined by NMR spectroscopy in combination with mass spectrometry, and their stereoconfigurations were established by chiral HPLC and by comparison of their optical rotations and NMR data with literature values.
References
-
- Barnes K, Folb P. Reducing malaria's burden: evidence of effectiveness for decision makers. Global Health Council; Washington, DC: 2003. pp. 25–32. technical report.
-
- Panosian CB. Clin Infect Dis. 2005;40:713–717. - PubMed
-
- Corbett Y, Herrera L, González J, Cubilla L, Capson TL, Coley PD, Kursar TA, Romero LI, Ortega-Barria E. Am J Trop Med Hyg. 2004;70:119–124. - PubMed
-
- Papendorf O, Konig GM, Wright AD. Phytochemistry. 1998;49:2383–2386. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
